Mark Eisner, EVP and Chief Medical Officer: Vir Biotechnology VIR Sell · Filed 02/26

Trade details

Type: Insider sale
Amount: $15,400.48
Shares · price: 1,616 sh · $9.53 a share
Held after: 155,913 sh
Stock: Vir Biotechnology VIR
Person: Mark EisnerEVP and Chief Medical Officer
Trade date: 26/02/24
Filed: 26/02/26
Days to filing: 2 days

Sold 1.0% of holdings

Share of holding sold: 1.0%

Vir Biotechnology trades, last 26 weeks

What else happened in Vir Biotechnology around then

Filed or reported within 30 days of the trade day · 01/25~03/26

Mark Eisner's recent trades

Mark EisnerFormer Officer
Planned saleVir Biotechnology
Planned sale
Vir Biotechnology
VIR
$916.3K
88,958 sh
$916.3K
Filed 04/30
Traded 04/30
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/26
Traded 02/25
Mark EisnerOfficer
Planned sale10b5-1 planVir Biotechnology
Planned sale10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/25
Traded 02/25
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$15.6K
2,089 sh
$15.6K
Filed 02/24
Traded 02/23
Mark EisnerOfficer
Planned saleVir Biotechnology
Planned sale
Vir Biotechnology
VIR
$15.4K
1,616 sh
$15.4K
Filed 02/24
Traded 02/24

Mark Eisner, Chief Officer — sold $15.4K of Vir Biotechnology VIR · 1.0% of holdings · 10b5-1 plan | Whalegun